← Back to headlines
Roche Shares Drop as Breast Cancer Drug Fails Trial
Shares of pharmaceutical giant Roche have dropped following the failure of its oral breast cancer drug in a clinical trial. This setback impacts the company's oncology pipeline.
9 Mar, 08:54 — 9 Mar, 08:54
Sources
Showing 1 of 1 sources
